Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$98.32 USD

98.32
21,578,090

-0.84 (-0.85%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $98.81 +0.49 (0.50%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 43% (106 out of 247)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.

Zacks Equity Research

Can Cigna (CI) Sustain its Earnings Surprise Streak in Q4?

by Zacks Equity Research

We expect Cigna Corp. (CI) to beat earnings expectations when it reports fourth-quarter and full-year 2016 results, on Feb 2.

    Zacks Equity Research

    Rite Aid Down on Walgreens Deal Offer Price Cut & Delay

    by Zacks Equity Research

    Rite Aid Corp. (RAD) and Walgreens Boots Alliance Inc. (WBA) jointly agreed upon a Jul 31, 2017 deadline for the deal and slashed the offer price to accommodate more store divestitures that would help gain regulatory approval.

      Zacks Equity Research

      Paylocity Holding (PCTY) Q2 Earnings: What's in the Cards?

      by Zacks Equity Research

      Paylocity Holding Corporation (PCTY) is set to report second-quarter fiscal 2017 results on Feb 2.

        Zacks Equity Research

        Teladoc (TDOC) to Report Q4 Earnings: What's in Store? (revised)

        by Zacks Equity Research

        Telehealth provider Teladoc Inc. (TDOC) has not confirmed the time/date for its December-quarter earnings release yet, but the report will likely be fairly soon, as they last reported quarterly results on October 27, 2016.

          Zacks Equity Research

          NXP Semiconductors (NXPI) Q4 Earnings: Will it Surprise?

          by Zacks Equity Research

          NXP Semiconductors NV (NXPI) is set to report fourth-quarter 2016 results on Feb 1.

            Zacks Equity Research

            CVS Health (CVS) Q4 Earnings: A Beat in Store for the Stock?

            by Zacks Equity Research

            We expect pharmacy innovation company CVS Health Corporation (CVS) to beat expectations when it reports fourth-quarter 2016 results on Feb 9.

              Zacks Equity Research

              Teladoc (TDOC) to Report Q4 Earnings: What's in Store?

              by Zacks Equity Research

              Telehealth provider, Teladoc Inc. (TDOC ) is scheduled to report fourth-quarter and full-year 2016 results on Jan 27.

                Madeleine Johnson headshot

                CVS Debuts Cheap EpiPen Alternative

                by Madeleine Johnson

                On Thursday, leading drug store chain CVS Health Corp. (CVS) announced that it is now selling a cheaper alternative to Mylan's (MYL) EpiPen.

                  Zacks Equity Research

                  CVS Health Introduces Transform Diabetes Care Program

                  by Zacks Equity Research

                  CVS Health Corporation (CVS) recently unveils Transform Diabetes Care Program which will help the company's PBM clients improve health outcome of diabetic patients.

                    Zacks Equity Research

                    CVS Health Revises View for 2016 & 2017, Declares Dividend

                    by Zacks Equity Research

                    CVS Health Corporation (CVS) recently announced strategies to drive long-term growth and shareholders' value.